Step by Step






Credit Hours: CME 1.00

Target Audience:

This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Review the literature on COVID-19 up to this point.
  • Review Coronaviruses and they virology, specifically the aspects that make them more likely to mutate and cause epidemics.
  • Review presentation of patients and treatments that have been done up to this point for COVID-19.
  • There is no educational content to this course. This course is designed to only administer the post-test and collect CME evaluations for the podcast associated with this training.

Suggested Additional Reading:

  1. Taubenberger JK, Hultin JV, Morens DM. Discovery and characterization of the 1918 pandemic influenza virus in historical context. Antivir Ther. 2007;12(4 Pt B):581–591.
  2. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. Published online February 07, 2020. doi:10.1001/jama.2020.1585
  3. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention [published online ahead of print, 2020 Feb 24]. JAMA. 2020;10.1001/jama.2020.2648. doi:10.1001/jama.2020.2648
  4. Battegay M, Kuehl R, Tschudin-Sutter S, Hirsch HH, Widmer AF, Neher RA. 2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate - a word of caution. Swiss Med Wkly. 2020;150:w20203. Published 2020 Feb 7. doi:10.4414/smw.2020.20203
  5. Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of Novel Coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis [published online ahead of print, 2020 Feb 22]. Int J Infect Dis. 2020;S1201-9712(20)30091-6. doi:10.1016/j.ijid.2020.02.033
  6. Soucheray, S. Study of 72,000 COVID-19 patients finds 2.3% death rate. CIDRAP News. Feb 24, 2020
  7. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30;:]. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
  8. Guan W, Ni Z, Hu Y, Liang W et al. Clinical Characteristics of Coronavirus Disease 2019 in China. NEJM. Feb 28, 2020.
  9. Gates, B. Responding to Covid-19 — A Once-in-a-Century Pandemic? NEJM. Feb 28, 2020.
  10. Expert Group on Prevention and Control of New Coronavirus Pneumonia of Chinese Preventative Medicine Association. New understanding of epidemiological characteristics of new coronavirus pneumonia. Chinese Journal of Epidemiology, 2020. DOI: 10.3760

John V. Williams, MD — Chief of the Division of Pediatric Infectious Diseases, Children’s Hospital of Pittsburgh of UPMC
Professor, Department of Pediatrics, University of Pittsburgh School of Medicine
Member, Molecular Virology and Microbiology Graduate Program
Dr. Williams is a member of the Scientific Advisory Board for Quidel and ID Connect; Independent Data Monitoring Committee for GlaxoSmithKline
Megan Culler Freeman, MD — PL-2 RESIDENT, Department of Pediatrics, Children's Hospital of Pittsburgh
No relationships with industry relevant to the content of this educational activity have been disclosed.
Tony R. Tarchichi MD — Assistant Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C . Gaffney Diagnostic Referral Group
No relationships with industry relevant to the content of this educational activity have been disclosed.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.